Cargando…
General Sensitization of Melanoma Cells for TRAIL-Induced Apoptosis by the Potassium Channel Inhibitor TRAM-34 Depends on Release of SMAC
The death ligand TRAIL represents a promising therapeutic strategy for metastatic melanoma, however prevalent and inducible resistance limit its applicability. A new approach is presented here for sensitization to TRAIL. It is based on inhibition of the membrane potassium channel KCa3.1 (IK1), which...
Autores principales: | Quast, Sandra-Annika, Berger, Anja, Buttstädt, Nicole, Friebel, Kristin, Schönherr, Roland, Eberle, Jürgen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3377761/ https://www.ncbi.nlm.nih.gov/pubmed/22723988 http://dx.doi.org/10.1371/journal.pone.0039290 |
Ejemplares similares
-
Critical role of reactive oxygen species (ROS) for synergistic enhancement of apoptosis by vemurafenib and the potassium channel inhibitor TRAM-34 in melanoma cells
por: Bauer, Daniel, et al.
Publicado: (2017) -
Countering TRAIL Resistance in Melanoma
por: Eberle, Jürgen
Publicado: (2019) -
ROS-dependent phosphorylation of Bax by wortmannin sensitizes melanoma cells for TRAIL-induced apoptosis
por: Quast, S-A, et al.
Publicado: (2013) -
Novel SMAC-mimetics synergistically stimulate melanoma cell death in combination with TRAIL and Bortezomib
por: Lecis, D, et al.
Publicado: (2010) -
Sensitization of melanoma cells for TRAIL-induced apoptosis by BMS-345541 correlates with altered phosphorylation and activation of Bax
por: Berger, A, et al.
Publicado: (2013)